169 related articles for article (PubMed ID: 35097133)
21. Therapeutic Efficacy of a Subunit Vaccine in Controlling Chronic Trypanosoma cruzi Infection and Chagas Disease Is Enhanced by Glutathione Peroxidase Over-Expression.
Gupta S; Smith C; Auclair S; Delgadillo Ade J; Garg NJ
PLoS One; 2015; 10(6):e0130562. PubMed ID: 26075398
[TBL] [Abstract][Full Text] [Related]
22. Role of SOCS2 in modulating heart damage and function in a murine model of acute Chagas disease.
Esper L; Roman-Campos D; Lara A; Brant F; Castro LL; Barroso A; Araujo RR; Vieira LQ; Mukherjee S; Gomes ER; Rocha NN; Ramos IP; Lisanti MP; Campos CF; Arantes RM; Guatimosim S; Weiss LM; Cruz JS; Tanowitz HB; Teixeira MM; Machado FS
Am J Pathol; 2012 Jul; 181(1):130-40. PubMed ID: 22658486
[TBL] [Abstract][Full Text] [Related]
23. IL-32γ promotes the healing of murine cutaneous lesions caused by Leishmania braziliensis infection in contrast to Leishmania amazonensis.
Gomes RS; Silva MVT; Dos Santos JC; de Lima Silva LL; Batista AC; Machado JR; Teixeira MM; Dorta ML; de Oliveira MAP; Dinarello CA; Joosten LAB; Ribeiro-Dias F
Parasit Vectors; 2017 Jul; 10(1):336. PubMed ID: 28709468
[TBL] [Abstract][Full Text] [Related]
24. Immunopathological aspects of experimental Trypanosoma cruzi reinfections.
Reis Machado J; Silva MV; Borges DC; da Silva CA; Ramirez LE; dos Reis MA; Castellano LR; Rodrigues V; Rodrigues DB
Biomed Res Int; 2014; 2014():648715. PubMed ID: 25050370
[TBL] [Abstract][Full Text] [Related]
25. Coinfection with different Trypanosoma cruzi strains interferes with the host immune response to infection.
Rodrigues CM; Valadares HM; Francisco AF; Arantes JM; Campos CF; Teixeira-Carvalho A; Martins-Filho OA; Araujo MS; Arantes RM; Chiari E; Franco GR; Machado CR; Pena SD; Faria AM; Macedo AM
PLoS Negl Trop Dis; 2010 Oct; 4(10):e846. PubMed ID: 20967289
[TBL] [Abstract][Full Text] [Related]
26. Oral Route Driven Acute
Antunes D; Marins-Dos-Santos A; Ramos MT; Mascarenhas BAS; Moreira CJC; Farias-de-Oliveira DA; Savino W; Monteiro RQ; de Meis J
Front Immunol; 2019; 10():1073. PubMed ID: 31139194
[TBL] [Abstract][Full Text] [Related]
27. Treatment of chronically Trypanosoma cruzi-infected mice with a CCR1/CCR5 antagonist (Met-RANTES) results in amelioration of cardiac tissue damage.
Medeiros GA; Silvério JC; Marino AP; Roffê E; Vieira V; Kroll-Palhares K; Carvalho CE; Silva AA; Teixeira MM; Lannes-Vieira J
Microbes Infect; 2009 Feb; 11(2):264-73. PubMed ID: 19100857
[TBL] [Abstract][Full Text] [Related]
28. During Trypanosoma cruzi infection CD1d-restricted NK T cells limit parasitemia and augment the antibody response to a glycophosphoinositol-modified surface protein.
Duthie MS; Wleklinski-Lee M; Smith S; Nakayama T; Taniguchi M; Kahn SJ
Infect Immun; 2002 Jan; 70(1):36-48. PubMed ID: 11748161
[TBL] [Abstract][Full Text] [Related]
29. Increased Trypanosoma cruzi invasion and heart fibrosis associated with high transforming growth factor beta levels in mice deficient in alpha(2)-macroglobulin.
Waghabi MC; Coutinho CM; Soeiro MN; Pereira MC; Feige JJ; Keramidas M; Cosson A; Minoprio P; Van Leuven F; Araújo-Jorge TC
Infect Immun; 2002 Sep; 70(9):5115-23. PubMed ID: 12183561
[TBL] [Abstract][Full Text] [Related]
30. The Colombian Strain of
do Carmo Neto JR; da Costa AWF; Braga YLL; Lucio FH; Dos Santos Martins ALM; Dos Reis MA; de Oliveira FA; Celes MRN; da Silva MV; Oliveira MAP; Machado JR
Mediators Inflamm; 2022; 2022():7641357. PubMed ID: 35069009
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-12-mediated resistance to Trypanosoma cruzi is dependent on tumor necrosis factor alpha and gamma interferon.
Hunter CA; Slifer T; Araujo F
Infect Immun; 1996 Jul; 64(7):2381-6. PubMed ID: 8698455
[TBL] [Abstract][Full Text] [Related]
32. Different infective forms trigger distinct immune response in experimental Chagas disease.
Vieira PM; Francisco AF; Machado EM; Nogueira NC; Fonseca Kda S; Reis AB; Teixeira-Carvalho A; Martins-Filho OA; Tafuri WL; Carneiro CM
PLoS One; 2012; 7(3):e32912. PubMed ID: 22412949
[TBL] [Abstract][Full Text] [Related]
33. STING Signaling Drives Production of Innate Cytokines, Generation of CD8
Vieira RS; Nascimento MS; Noronha IH; Vasconcelos JRC; Benvenuti LA; Barber GN; Câmara NOS; Kalil J; Cunha-Neto E; Almeida RR
Front Immunol; 2021; 12():775346. PubMed ID: 35095849
[TBL] [Abstract][Full Text] [Related]
34. Analysis of the dynamics of infiltrating CD4(+) T cell subsets in the heart during experimental Trypanosoma cruzi infection.
Sanoja C; Carbajosa S; Fresno M; Gironès N
PLoS One; 2013; 8(6):e65820. PubMed ID: 23776551
[TBL] [Abstract][Full Text] [Related]
35. Perforin-expressing cytotoxic cells contribute to chronic cardiomyopathy in Trypanosoma cruzi infection.
Silverio JC; de-Oliveira-Pinto LM; da Silva AA; de Oliveira GM; Lannes-Vieira J
Int J Exp Pathol; 2010 Feb; 91(1):72-86. PubMed ID: 19878357
[TBL] [Abstract][Full Text] [Related]
36. IL-4 reduces resistance of mice to Trypanosoma cruzi infection.
Hiyama K; Hamano S; Nakamura T; Nomoto K; Tada I
Parasitol Res; 2001 Apr; 87(4):269-74. PubMed ID: 11355674
[TBL] [Abstract][Full Text] [Related]
37. Tumor necrosis factor alpha-mediated toxic shock in Trypanosoma cruzi-infected interleukin 10-deficient mice.
Hölscher C; Mohrs M; Dai WJ; Köhler G; Ryffel B; Schaub GA; Mossmann H; Brombacher F
Infect Immun; 2000 Jul; 68(7):4075-83. PubMed ID: 10858224
[TBL] [Abstract][Full Text] [Related]
38. 4-aminopyridyl-based lead compounds targeting CYP51 prevent spontaneous parasite relapse in a chronic model and improve cardiac pathology in an acute model of Trypanosoma cruzi infection.
Calvet CM; Choi JY; Thomas D; Suzuki B; Hirata K; Lostracco-Johnson S; de Mesquita LB; Nogueira A; Meuser-Batista M; Silva TA; Siqueira-Neto JL; Roush WR; de Souza Pereira MC; McKerrow JH; Podust LM
PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006132. PubMed ID: 29281643
[TBL] [Abstract][Full Text] [Related]
39. Cytokine responses in Trypanosoma cruzi-infected children in Paraguay.
Samudio M; Montenegro-James S; Cabral M; Martinez J; Rojas de Arias A; James MA
Am J Trop Med Hyg; 1998 Jan; 58(1):119-21. PubMed ID: 9452302
[TBL] [Abstract][Full Text] [Related]
40. Vasoactive intestinal peptide reduces the inflammatory profile in mice infected with Trypanosoma cruzi.
Higyno PM; Mendes PF; Miranda MB; Pereira DE; Mota AP; Nogueira Kde O; Caldas IS; Moura SA; Menezes CA
Exp Parasitol; 2015 Dec; 159():72-8. PubMed ID: 26358268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
